STOCK TITAN

Cybeats Commences Pilot with Top 5 Global Medical Device Manufacturer

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

Cybeats Technologies Corp. (CSE: CYBT) (OTCQB: CYBCF) has announced a new pilot engagement with a top-five global medical device manufacturer (MDM). This development highlights the company's growing presence in the medical device sector, as Cybeats is already serving three of the top ten largest global MDMs worldwide. The company's SBOM Studio product addresses urgent cybersecurity market needs, particularly in light of new FDA requirements for the use of Software Bills of Materials (SBOMs) in the healthcare sector.

SBOM Studio has demonstrated significant ROI for clients, with one Fortune 500 client reporting a 75% reduction in effort for software-based projects, translating to approximately $50,000 USD in savings per project. The global healthcare cybersecurity market, currently valued at $18 billion, is expected to grow at 14.2% annually, reaching over $35 billion by 2028.

Cybeats Technologies Corp. (CSE: CYBT) (OTCQB: CYBCF) ha annunciato un nuovo progetto pilota con un produttore di dispositivi medici tra i primi cinque a livello globale (MDM). Questo sviluppo evidenzia la crescente presenza dell'azienda nel settore dei dispositivi medici, poiché Cybeats sta già servendo tre dei dieci maggiori MDM a livello mondiale. Il prodotto SBOM Studio dell'azienda risponde a esigenze urgenti del mercato della cybersicurezza, in particolare alla luce dei nuovi requisiti della FDA per l'uso delle Software Bills of Materials (SBOM) nel settore sanitario.

SBOM Studio ha dimostrato un ROI significativo per i clienti, con un cliente della Fortune 500 che ha riportato una riduzione del 75% dello sforzo per i progetti basati su software, traducendosi in un risparmio di circa 50.000 USD per progetto. Il mercato globale della cybersicurezza nella sanità, attualmente valutato 18 miliardi di dollari, è previsto crescere del 14,2% all'anno, raggiungendo oltre 35 miliardi di dollari entro il 2028.

Cybeats Technologies Corp. (CSE: CYBT) (OTCQB: CYBCF) ha anunciado un nuevo proyecto piloto con un fabricante de dispositivos médicos entre los cinco principales a nivel mundial (MDM). Este desarrollo destaca la creciente presencia de la empresa en el sector de dispositivos médicos, ya que Cybeats está sirviendo a tres de los diez MDM más grandes a nivel mundial. El producto SBOM Studio de la empresa aborda necesidades urgentes del mercado de ciberseguridad, especialmente a la luz de los nuevos requisitos de la FDA para el uso de Software Bills of Materials (SBOM) en el sector salud.

SBOM Studio ha demostrado un ROI significativo para los clientes, con un cliente de Fortune 500 informando una reducción del 75% en el esfuerzo para proyectos basados en software, lo que se traduce en aproximadamente 50,000 USD en ahorros por proyecto. El mercado global de ciberseguridad en el sector salud, actualmente valorado en 18 mil millones de dólares, se espera que crezca un 14.2% anualmente, alcanzando más de 35 mil millones de dólares para 2028.

Cybeats Technologies Corp. (CSE: CYBT) (OTCQB: CYBCF)는 세계적으로 상위 5개 의료기기 제조업체(MDM)와 새로운 파일럿 프로젝트를 발표했습니다. 이 발전은 Cybeats가 이미 세계 10대 MDM 중 3곳을 대상으로 서비스를 제공하는 등 의료기기 분야에서의 회사의 성장하는 존재감을 강조합니다. 회사의 SBOM Studio 제품은 의료 분야에서 소프트웨어 자재 명세서(SBOM)의 사용을 위한 FDA의 새로운 요구 사항에 비추어, 급박한 사이버 보안 시장 요구를 해결합니다.

SBOM Studio는 고객에게 상당한 ROI를 입증했으며, 한 Fortune 500 고객은 소프트웨어 기반 프로젝트의 노력에서 75%의 감소를 보고하여, 프로젝트당 약 50,000 USD의 절감 효과를 나타냈습니다. 현재 180억 달러로 평가받고 있는 글로벌 헬스케어 사이버 보안 시장은 매년 14.2% 성장하여 2028년까지 350억 달러를 초과할 것으로 예상됩니다.

Cybeats Technologies Corp. (CSE: CYBT) (OTCQB: CYBCF) a annoncé un nouvel engagement pilote avec un fabricant d'appareils médicaux parmi les cinq plus grands au monde (MDM). Ce développement souligne la présence croissante de l'entreprise dans le secteur des dispositifs médicaux, alors que Cybeats sert déjà trois des dix plus grands MDM à l'échelle mondiale. Le produit SBOM Studio de l'entreprise répond à des besoins urgents du marché de la cybersécurité, notamment à la lumière des nouvelles exigences de la FDA concernant l'utilisation des Software Bills of Materials (SBOM) dans le secteur de la santé.

SBOM Studio a démontré un retour sur investissement significatif pour les clients, un client de la Fortune 500 rapportant une réduction de 75% de l’effort pour les projets basés sur des logiciels, ce qui correspond à environ 50 000 USD d’économies par projet. Le marché mondial de la cybersécurité des soins de santé, actuellement évalué à 18 milliards USD, devrait croître de 14,2% par an, atteignant plus de 35 milliards USD d'ici 2028.

Cybeats Technologies Corp. (CSE: CYBT) (OTCQB: CYBCF) hat eine neue Pilotlösung mit einem der fünf größten globalen Hersteller von Medizinprodukten (MDM) angekündigt. Diese Entwicklung hebt die wachsende Präsenz des Unternehmens im Sektor der Medizinprodukte hervor, da Cybeats bereits drei der zehn größten MDMs weltweit bedient. Das Produkt SBOM Studio des Unternehmens erfüllt dringende Anforderungen des Cybersecurity-Marktes, insbesondere angesichts der neuen Anforderungen der FDA zur Nutzung von Software-Baumateriallisten (SBOM) im Gesundheitswesen.

SBOM Studio hat bei Kunden eine signifikante Rendite erzielt, wobei ein Fortune-500-Kunde von einer 75%igen Reduzierung des Aufwands bei softwarebasierten Projekten berichtete, was zu Einsparungen von etwa 50.000 USD pro Projekt führte. Der globale Markt für Cybersecurity im Gesundheitswesen, der derzeit auf 18 Milliarden USD geschätzt wird, wird voraussichtlich jährlich um 14,2% wachsen und bis 2028 über 35 Milliarden USD erreichen.

Positive
  • New pilot engagement with a top-five global medical device manufacturer
  • Already serving three of the top ten largest global MDMs worldwide
  • High conversion rate on pilots into commercial contracts
  • SBOM Studio demonstrated 75% effort reduction for a Fortune 500 client, saving approximately $50,000 USD per project
  • Addressing urgent cybersecurity market needs in the healthcare sector
  • Partnership with Health Information Sharing and Analysis Center (H-ISAC)
Negative
  • None.

Toronto, Ontario--(Newsfile Corp. - July 31, 2024) - Cybeats Technologies Corp. (CSE: CYBT) (OTCQB: CYBCF) ("Cybeats'' or the "Company"), is pleased to announce a new pilot engagement with a top-five global medical device manufacturer ("MDM"). Cybeats is already serving three of the top ten largest global MDMs worldwide, and maintains a high conversion rate on pilots[2] into commercial contracts.[3]

"Commencing another pilot with a leader from the medical device space highlights the value and efficacy of SBOM Studio and the teams' capacity to service some of the largest companies worldwide. The product solves urgent cybersecurity market needs, especially with regulatory shifts in the healthcare sector that include mandated FDA requirements for the use of SBOMs," said Justin Leger, CEO, Cybeats.

SBOM Studio helps its clients achieve improved cybersecurity outcomes and significant ROI by automating and streamlining the software vulnerability lifecycle and SBOM management. One global Fortune 500 client of Cybeats saw a reduction of approximately 500 hours of effort for software-based projects with open-source components, representing 75% -or an estimated $50,000 USD- in savings per project. With the key benefits of vulnerability monitoring, automated risk analysis, and regulatory compliance, SBOM Studio serves a broad range of users in the software supply chain. As a global cybersecurity Company, Cybeats is proud to serve the needs of a diverse blue-chip customer base and is an emerging pioneer with the most compelling product offering for managing SBOM.[4]

The FDA's role in regulating cybersecurity for medical devices has significantly increased as the FDA can now reject or approve premarket submissions for medical devices based on whether they meet section 524B of the Federal Food, Drug, and Cosmetic Act (FD&C Act). An important section 524B requirement is that medical device manufacturers (MDMs) provide a SBOM for the device's commercial, open source and off-the-shelf software components.[5]

Cybeats is a proud partner of the Health Information Sharing and Analysis Center (H-ISAC)[6]: a global organization focused on enhancing cyber and physical security in the healthcare industry.[7] The global healthcare cybersecurity market is valued at approximately $18 billion and is expected to grow at 14.2% annually to over $35 billion by 2028[8].

Learn more here about how Cybeats can help you to manage risk and meet evolving cyber regulatory requirements.

About Cybeats

Cybeats is a cybersecurity company providing Software Bill of Material (SBOM) management and software supply chain intelligence technology, helping organizations to manage risk, meet compliance requirements, and secure their software from procurement to development and operation. Our platform gives customers comprehensive visibility and transparency into their software supply chain, enabling them to improve operational efficiency and increase revenue. Cybeats. Software Made Certain. Website: https://cybeats.com

SUBSCRIBE: For more information, or to subscribe to the Company's mail list, visit: https://www.cybeats.com/investors

Contact:

James Van Staveren
Corporate Development
Phone: 1-888-713-SBOM (7266)
Email: ir@cybeats.com

Forward-looking Information Cautionary Statement

Except for statements of historic fact, this news release contains certain "forward-looking information" within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements are based on the opinions and estimates at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements including, but not limited to delays or uncertainties with regulatory approvals, including that of the CSE. There are uncertainties inherent in forward-looking information, including factors beyond the Company's control. There are no assurances that the commercialization plans for the products described in this news release will come into effect on the terms or time frame described herein. The Company undertakes no obligation to update forward-looking information if circumstances or management's estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements. Company filings are available at sedarplus.ca.


[1] https://www.cybeats.com/sbom-studio
[2]https://www.cybeats.com/news/cybeats-provides-corporate-update-significant-commercial-delivery-and-strategic-positioning-to-capitalize-on-sector-growth
[3]https://www.cybeats.com/news/cybeats-signs-commercial-agreement-with-a-top-3-global-medical-device-and-diagnostics-company
[4] https://www.cisa.gov/sbom
[5] FD&C Act section 524B "Ensuring Cybersecurity of Devices", para. (b) (3).
[6] https://h-isac.org/
[7]https://www.cybeats.com/news/cybeats-partners-with-health-isac-a-global-healthcare-cyber-physical-security-organization-to-deliver-joint-commercial-solution-health-isac-sbom-studio
[8] https://www.marketsandmarkets.com/Market-Reports/healthcare-cybersecurity-market-215097518.html

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/218373

FAQ

What is the new pilot engagement announced by Cybeats Technologies Corp. (CYBCF)?

Cybeats Technologies Corp. (CYBCF) has announced a new pilot engagement with a top-five global medical device manufacturer (MDM).

How many top global medical device manufacturers does Cybeats currently serve?

Cybeats is currently serving three of the top ten largest global medical device manufacturers worldwide.

What are the key benefits of Cybeats' SBOM Studio product?

The key benefits of SBOM Studio include vulnerability monitoring, automated risk analysis, regulatory compliance, and significant ROI through automation and streamlining of the software vulnerability lifecycle and SBOM management.

What is the projected growth of the global healthcare cybersecurity market according to the Cybeats (CYBCF) press release?

The global healthcare cybersecurity market is expected to grow from its current value of $18 billion to over $35 billion by 2028, with an annual growth rate of 14.2%.

How does SBOM Studio by Cybeats (CYBCF) help clients achieve ROI?

SBOM Studio helps clients achieve ROI by automating and streamlining the software vulnerability lifecycle and SBOM management. One Fortune 500 client reported a 75% reduction in effort for software-based projects, saving approximately $50,000 USD per project.

CYBEATS TECHNOLOGIES CORP

OTC:CYBCF

CYBCF Rankings

CYBCF Latest News

CYBCF Stock Data

14.07M
114.28M
1.77%
Software - Infrastructure
Technology
Link
United States of America
Toronto